{"id":"3c86e973-7af5-5ee5-b9c2-d9826ff8cbc3","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-review-efficacy-scope","predicate":"improves","statement":"The review reports that systematic reviews and randomised clinical trials support clinical use of hyperbaric oxygen for refractory diabetic wound healing and radiation injuries, while compromised flaps, grafts and ischaemia-reperfusion disorders are supported by animal studies and a small number of clinical trials.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"1f55888d-8b01-5341-a689-2cd00917f193","mechanism_event_label":"The evidence is strongest for stubborn diabetic wounds and radiation damage, and thinner elsewhere.","subject":{"id":"581fa746-cb84-571b-87a0-4d461263f660","slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"},"object":{"id":"cfa217ea-8fe4-5c5a-97ff-469e2ece88c7","slug":"wound-healing","display_name":"Wound healing","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"1f55888d-8b01-5341-a689-2cd00917f193","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-review-efficacy-scope-event","event_type":"observed_intervention","label":"The evidence is strongest for stubborn diabetic wounds and radiation damage, and thinner elsewhere.","description":"The review reports that systematic reviews and randomised clinical trials support clinical use of hyperbaric oxygen for refractory diabetic wound healing and radiation injuries, while compromised flaps, grafts and ischaemia-reperfusion disorders are supported by animal studies and a small number of clinical trials.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"edf44fa2-6b85-590d-916f-89a6b3fd512d","slug":"radiation-proctitis-severity","display_name":"Refractory radiation proctitis severity by SOMA-LENT score","entity_type_key":"cellular_process"},"role":"other_indication","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"581fa746-cb84-571b-87a0-4d461263f660","slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"cfa217ea-8fe4-5c5a-97ff-469e2ece88c7","slug":"wound-healing","display_name":"Wound healing","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/hbot-research/21200283.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"541f2eb700a843e35093e589069b7839f1a3577c2de8cd1edb444698c1379380\", \"start_char\": 0, \"end_char\": 1120, \"text_sha256\": \"541f2eb700a843e35093e589069b7839f1a3577c2de8cd1edb444698c1379380\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Narrative review of therapeutic mechanisms and clinical trial evidence","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Hyperbaric oxygen as used clinically, typically 2.0 to 2.5 atmospheres absolute","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A narrative review, not a primary experiment. It is recorded as the framing source the reader was given; every mechanism it names is also recorded here from its own primary paper.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human, with supporting animal work","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The evidence is strongest for stubborn diabetic wounds and radiation damage, and thinner elsewhere.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[hbot-p21200283] Hyperbaric oxygen: its mechanisms and efficacy. (2011). https://pubmed.ncbi.nlm.nih.gov/21200283/ DOI: 10.1097/prs.0b013e3181fbe2bf","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Multiple tissues","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"4b1a86a0-daa8-5e61-a123-acd59bf1b85a","evidence_kind":"source_excerpt","locator":"Lines 75-86","start_line":75,"end_line":86,"excerpt":"### hbot-review-efficacy-scope\nThe review reports that systematic reviews and randomised clinical trials support clinical use of hyperbaric oxygen for refractory diabetic wound healing and radiation injuries, while compromised flaps, grafts and ischaemia-reperfusion disorders are supported by animal studies and a small number of clinical trials.\nCondition category: normal\nnutrient_topic: Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.\nplain_language: The evidence is strongest for stubborn diabetic wounds and radiation damage, and thinner elsewhere.\norganism: Human, with supporting animal work\ntissue_or_cell_type: Multiple tissues\nexperimental_model: Narrative review of therapeutic mechanisms and clinical trial evidence\nlimitations: A narrative review, not a primary experiment. It is recorded as the framing source the reader was given; every mechanism it names is also recorded here from its own primary paper.\nexposure: Hyperbaric oxygen as used clinically, typically 2.0 to 2.5 atmospheres absolute\nevidence_span: {\"source_cache\": \"artifacts/hbot-research/21200283.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"541f2eb700a843e35093e589069b7839f1a3577c2de8cd1edb444698c1379380\", \"start_char\": 0, \"end_char\": 1120, \"text_sha256\": \"541f2eb700a843e35093e589069b7839f1a3577c2de8cd1edb444698c1379380\"}\n[hbot-p21200283] Hyperbaric oxygen: its mechanisms and efficacy. (2011). https://pubmed.ncbi.nlm.nih.gov/21200283/ DOI: 10.1097/prs.0b013e3181fbe2bf","model_system":"Narrative review of therapeutic mechanisms and clinical trial evidence","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [hbot-p21200283] Hyperbaric oxygen: its mechanisms and efficacy. (2011). https://pubmed.ncbi.nlm.nih.gov/21200283/ DOI: 10.1097/prs.0b013e3181fbe2bf","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"dbf39b48-c95e-5291-b404-349ffbc4488f","stable_key":"import-488ea171-36b8-5ef6-b5d3-98563980fdbf","title":"Hyperbaric oxygen: the exposure, its reactive species, the signals they carry, and the nutrient-dependent enzymes that handle them (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"fb2443321804010d82c6b96ab61cc51b4b6628ddbb15751cb0e90b491606e79c","revision_id":"bb699ea5-b492-5728-b22c-48f0842a8ac9","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}